| National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report AH Filipovich, D Weisdorf, S Pavletic, G Socie, JR Wingard, SJ Lee, ... Biology of blood and marrow transplantation 11 (12), 945-956, 2005 | 4101 | 2005 |
| National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working … MH Jagasia, HT Greinix, M Arora, KM Williams, D Wolff, EW Cowen, ... Biology of Blood and Marrow Transplantation 21 (3), 389-401. e1, 2015 | 2461 | 2015 |
| National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working … MH Jagasia, HT Greinix, M Arora, KM Williams, D Wolff, EW Cowen, ... Biology of Blood and Marrow Transplantation 21 (3), 389-401. e1, 2015 | 2461 | 2015 |
| ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells DW Lee, BD Santomasso, FL Locke, A Ghobadi, CJ Turtle, JN Brudno, ... Biology of blood and marrow transplantation 25 (4), 625-638, 2019 | 2166 | 2019 |
| Risk factors for acute GVHD and survival after hematopoietic cell transplantation M Jagasia, M Arora, MED Flowers, NJ Chao, PL McCarthy, CS Cutler, ... Blood, The Journal of the American Society of Hematology 119 (1), 296-307, 2012 | 794 | 2012 |
| T cells genetically modified to express an anti–B-cell maturation antigen chimeric antigen receptor cause remissions of poor-prognosis relapsed multiple myeloma JN Brudno, I Maric, SD Hartman, JJ Rose, M Wang, N Lam, ... Journal of Clinical Oncology 36 (22), 2267, 2018 | 703 | 2018 |
| Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation JN Kochenderfer, ME Dudley, RO Carpenter, SH Kassim, JJ Rose, ... Blood, The Journal of the American Society of Hematology 122 (25), 4129-4139, 2013 | 694 | 2013 |
| Allogeneic T cells that express an anti-CD19 chimeric antigen receptor induce remissions of B-cell malignancies that progress after allogeneic hematopoietic stem-cell … JN Brudno, RPT Somerville, V Shi, JJ Rose, DC Halverson, DH Fowler, ... Journal of clinical oncology 34 (10), 1112, 2016 | 640 | 2016 |
| Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft … HM Shulman, D Kleiner, SJ Lee, T Morton, SZ Pavletic, E Farmer, ... Biology of Blood and Marrow Transplantation 12 (1), 31-47, 2006 | 520 | 2006 |
| Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic … SZ Pavletic, P Martin, SJ Lee, S Mitchell, D Jacobsohn, EW Cowen, ... Biology of Blood and Marrow Transplantation 12 (3), 252-266, 2006 | 456 | 2006 |
| The biology of chronic graft-versus-host disease: a task force report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in … KR Cooke, L Luznik, S Sarantopoulos, FT Hakim, M Jagasia, DH Fowler, ... Biology of Blood and Marrow Transplantation 23 (2), 211-234, 2017 | 428 | 2017 |
| Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research S Arai, M Arora, T Wang, SR Spellman, W He, DR Couriel, ... Biology of Blood and Marrow Transplantation 21 (2), 266-274, 2015 | 420 | 2015 |
| Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD … J Pidala, B Kurland, X Chai, N Majhail, DJ Weisdorf, S Pavletic, C Cutler, ... Blood, The Journal of the American Society of Hematology 117 (17), 4651-4657, 2011 | 383 | 2011 |
| Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in … D Couriel, PA Carpenter, C Cutler, J Bolaños-Meade, NS Treister, ... Biology of Blood and Marrow Transplantation 12 (4), 375-396, 2006 | 382 | 2006 |
| Randomized phase III trial of fludarabine plus cyclophosphamide with or without oblimersen sodium (Bcl-2 antisense) in patients with relapsed or refractory chronic lymphocytic … S O'Brien, JO Moore, TE Boyd, LM Larratt, A Skotnicki, B Koziner, ... Journal of Clinical Oncology 25 (9), 1114-1120, 2007 | 373 | 2007 |
| Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic … SJ Lee, D Wolff, C Kitko, J Koreth, Y Inamoto, M Jagasia, J Pidala, ... Biology of Blood and Marrow Transplantation 21 (6), 984-999, 2015 | 359 | 2015 |
| Consensus conference on clinical practice in chronic GVHD: second-line treatment of chronic graft-versus-host disease D Wolff, M Schleuning, S von Harsdorf, U Bacher, A Gerbitz, M Stadler, ... Biology of Blood and Marrow Transplantation 17 (1), 1-17, 2011 | 329 | 2011 |
| EBMT− NIH− CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment HM Schoemans, SJ Lee, JL Ferrara, D Wolff, JE Levine, KR Schultz, ... Bone marrow transplantation 53 (11), 1401-1415, 2018 | 328 | 2018 |
| Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD D Wolff, A Gerbitz, F Ayuk, A Kiani, GC Hildebrandt, GB Vogelsang, ... Biology of Blood and Marrow Transplantation 16 (12), 1611-1628, 2010 | 309 | 2010 |
| High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis RA Nash, JD Bowen, PA McSweeney, SZ Pavletic, KR Maravilla, M Park, ... Blood 102 (7), 2364-2372, 2003 | 287 | 2003 |
